Ampa
Overview
Ampa is a neurotechnology company that makes Ampa One, a portable, lightweight, camera-guided, FDA-cleared TMS device. Ampa One is available via subscription with no upfront cost or per-treatment fee. Ampa One is pioneering One-Day TMS treatment and is designed to make an established therapy practical for practices that previously could not offer it. Founded by researchers who helped pioneer modern TMS protocols, Ampa's mission is to enable one billion remissions from mental and neurological disorders.
More in Neurotechnology
Latest industry news
China's Neurotech Ambitions Signal a New Frontier in the Global Brain Race
2026-10-18 · Industry
Functional Ultrasound BCIs Cross a Threshold: From Brain Reading to Two-Way Control
2026-10-17 · Research
Visual Cues Are Quietly Skewing BCI Accuracy Scores, and the Field Is Taking Notice
2026-10-16 · Research
ReVision Implant Secures €4 Million to Advance Neural Vision Restoration Technology
2026-10-15 · Funding
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-10
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →